Novo Nordisk missed his diversity goals last year and his CEO paid a financial price




In 2024, the CEO of Novo Nordisk took a reduction in wages of $ 1.5 million than the share price of the pharmaceutical tank and it missed profit and dei goals. Read more



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *